Published February 3, 2026 | Version v1

PaLaDIn - Improving Decision Making in Neuromuscular Diseases

Description

PaLaDIn (Patient Lifestyle and Disease Data Interactium) is a four-year Innovative Health Initiative-funded project launched in January 2024. Central to the success of the project is the Interactium®, a state-of-the-art data platform focused on collecting data directly from patients to improve decision making about their health, care, research, and treatment.

The project will pilot the approach in rare neuromuscular diseases (NMDs) before being scaled up to other rare diseases.

The PaLaDIn consortium brings several key players from the rare NMD field together including universities, SMEs, and several patient organisations. The partners involved in the PaLaDIn consortium are listed below:

  • Amsterdam University Medical Center (Netherlands)
  • Duchenne Parent Project aps (Italy)
  • Duchenne UK (United Kingdom)
  • Ephion Health (Spain)
  • Friedrich-Baur-Institut Munich (Germany)
  • FSHD Society (United States)
  • Institut de Recerca Sant Pau (Spain)
  • Leiden University Medical Center (Netherlands)
  • Newcastle University (United Kingdom)
  • TREAT-NMD (United Kingdom)

Files

PaLaDIn - Improving Decision Making in Neuromuscular Diseases.pdf

Files (32.1 MB)

Additional details

Funding

European Commission
Patient Lifestyle and Disease Data Interactium 101132943

Dates

Available
2026-02-03
Poster